The coronavirus disease 2019 (COVID-19) pandemic has truly been an all-hands-on-deck moment for the nation. Among the responders are many with NIH affiliations, lending their expertise and deploying new and emerging technologies to meet the myriad research challenges. That’s certainly the case for the NIH’s National Institute of Allergy and...
The coronavirus disease 2019 (COVID-19) pandemic has truly been an all-hands-on-deck moment for the nation. Among the responders are many with NIH affiliations, lending their expertise and deploying new and emerging technologies to meet the myriad research challenges. That’s certainly the case for the NIH’s National Institute of Allergy and Infectious Disease’s dedicated team at the NIH 3D Print Exchange (3DPX), Rockville, MD.
We now know that the immune system of nearly everyone who recovers from COVID-19 produces antibodies against SARS-CoV-2, the novel coronavirus that causes this easily transmitted respiratory disease [1] The presence of such antibodies has spurred hope that people exposed to SARS-CoV-2 may be protected, at least for a time, from getting COVID-19 again. But, in this post, I want to examine another potential use of antibodies: their promise for being developed as therapeutics for people who are sick with COVID-19.
Sheltering at home for more than two months has made many of us acutely aware of just how much we miss getting out and interacting with other human beings. For some, the coronavirus disease 2019 (COVID-19) pandemic has also triggered a more-selfless need: to be a good neighbor to the most vulnerable among us and help them stay safe and well, mentally and physically, during this trying time.
The coronavirus 2019 (COVD-19) pandemic has brought into sharp focus many of the troubling things that we already knew about health disparities in the United States but have failed to address. With the bright light now shining on this important issue, it is time to talk about the role research can play in reducing the disproportionate burden of COVID-19, as well as improving the health of all people in our great nation.
In the blog post “3D Printing the Novel Coronavirus,” I mentioned receiving my very own 3D-printed model of the novel coronavirus SARS-CoV-2, the cause of COVD-19. I shared this impressive model, created by the NIH 3D Print Exchange, with viewers during our third virtual NIH Town Hall meeting. The one-hour meeting was held on May […]
The USA Science & Engineering Festival just held its X-STEM All Access conference, though this year in a virtual format. It was my pleasure to videotape some brief remarks for the conference, and I offer them here to share the excitement and encourage young people to consider careers in the sciences. The opportunities that await […]
